Evaluation of Effect of Renal Impairment on the PK of Tenofovir Exalidex

NCT03284164 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Impairment

Interventions

DRUG: Tenofovir Exalidex (TXL)

Sponsor

ContraVir Pharmaceuticals, Inc.